J&J cell therapy gains edge over Bristol Myers rival
Jonathan Raa | Nurphoto | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Hi folks! Two competing cell …
Jonathan Raa | Nurphoto | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Hi folks! Two competing cell …
Recently, I read a terrific little book about Abraham Lincoln, called “Lincoln Reconsidered,” by Professor David Herbert Donald, and the fundamental premise behind the title was simple: If you want …
Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust will own 700 shares of ABT, …
The New York Stock Exchange welcomes Johnson & Johnson. NYSE Johnson & Johnson on Monday announced it is working with Nvidia to develop and scale new artificial intelligence applications for …
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | …
Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, …
Here are the most important news items that investors need to start their trading day: 1. Rates and robots For the main factors driving stocks, there are few bigger weeks …
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a …
Here are the most important news items that investors need to start their trading day: 1. Record run The S&P 500 closed at a record high on Friday. Now Wall …
CNBC’s Jim Cramer on Friday compared all NFL 14 teams competing in the playoffs to some of his top stock picks. “As I was reviewing this weekend’s slate of six …